316 related articles for article (PubMed ID: 34403963)
1. Immunomodulation effect of mesenchymal stem cells in islet transplantation.
Shrestha M; Nguyen TT; Park J; Choi JU; Yook S; Jeong JH
Biomed Pharmacother; 2021 Oct; 142():112042. PubMed ID: 34403963
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulatory and protective effects of adipose tissue-derived mesenchymal stem cells in an allograft islet composite transplantation for experimental autoimmune type 1 diabetes.
Mohammadi Ayenehdeh J; Niknam B; Rasouli S; Hashemi SM; Rahavi H; Rezaei N; Soleimani M; Liaeiha A; Niknam MH; Tajik N
Immunol Lett; 2017 Aug; 188():21-31. PubMed ID: 28506774
[TBL] [Abstract][Full Text] [Related]
3. Interleukin (IL)-10 induced by CD11b(+) cells and IL-10-activated regulatory T cells play a role in immune modulation of mesenchymal stem cells in rat islet allografts.
Kim YH; Wee YM; Choi MY; Lim DG; Kim SC; Han DJ
Mol Med; 2011; 17(7-8):697-708. PubMed ID: 21365122
[TBL] [Abstract][Full Text] [Related]
4. The Unique Immunomodulatory Properties of MSC-Derived Exosomes in Organ Transplantation.
Zheng Q; Zhang S; Guo WZ; Li XK
Front Immunol; 2021; 12():659621. PubMed ID: 33889158
[TBL] [Abstract][Full Text] [Related]
5. Reduction of marginal mass required for successful islet transplantation in a diabetic rat model using adipose tissue-derived mesenchymal stromal cells.
Navaei-Nigjeh M; Moloudizargari M; Baeeri M; Gholami M; Lotfibakhshaiesh N; Soleimani M; Vasheghani-Farahani E; Ai J; Abdollahi M
Cytotherapy; 2018 Sep; 20(9):1124-1142. PubMed ID: 30068495
[TBL] [Abstract][Full Text] [Related]
6. The Immunomodulatory Properties of the Human Amnion-Derived Mesenchymal Stromal/Stem Cells Are Induced by INF-γ Produced by Activated Lymphomonocytes and Are Mediated by Cell-To-Cell Contact and Soluble Factors.
Bulati M; Miceli V; Gallo A; Amico G; Carcione C; Pampalone M; Conaldi PG
Front Immunol; 2020; 11():54. PubMed ID: 32117234
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells prevent acute rejection and prolong graft function in pancreatic islet transplantation.
Longoni B; Szilagyi E; Quaranta P; Paoli GT; Tripodi S; Urbani S; Mazzanti B; Rossi B; Fanci R; Demontis GC; Marzola P; Saccardi R; Cintorino M; Mosca F
Diabetes Technol Ther; 2010 Jun; 12(6):435-46. PubMed ID: 20470228
[TBL] [Abstract][Full Text] [Related]
8. Utility of co-transplanting mesenchymal stem cells in islet transplantation.
Sakata N; Goto M; Yoshimatsu G; Egawa S; Unno M
World J Gastroenterol; 2011 Dec; 17(47):5150-5. PubMed ID: 22215938
[TBL] [Abstract][Full Text] [Related]
9. Immunomodulatory mechanisms of mesenchymal stem cells and their therapeutic applications.
Lee DK; Song SU
Cell Immunol; 2018 Apr; 326():68-76. PubMed ID: 28919171
[TBL] [Abstract][Full Text] [Related]
10. Potential role of mesenchymal stromal cells in pancreatic islet transplantation.
Hematti P; Kim J; Stein AP; Kaufman D
Transplant Rev (Orlando); 2013 Jan; 27(1):21-9. PubMed ID: 23290684
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem-cell immunosuppressive capabilities: therapeutic implications in islet transplantation.
Ding Y; Bushell A; Wood KJ
Transplantation; 2010 Feb; 89(3):270-3. PubMed ID: 20145515
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive properties of mesenchymal stem cells: advances and applications.
De Miguel MP; Fuentes-Julián S; Blázquez-Martínez A; Pascual CY; Aller MA; Arias J; Arnalich-Montiel F
Curr Mol Med; 2012 Jun; 12(5):574-91. PubMed ID: 22515979
[TBL] [Abstract][Full Text] [Related]
13. Multipotent Mesenchymal Stromal Cells Interact and Support Islet of Langerhans Viability and Function.
Koehler N; Buhler L; Egger B; Gonelle-Gispert C
Front Endocrinol (Lausanne); 2022; 13():822191. PubMed ID: 35222280
[TBL] [Abstract][Full Text] [Related]
14. Potential of mesenchymal stromal cells for improving islet transplantation outcomes.
Rackham CL; Jones PM
Curr Opin Pharmacol; 2018 Dec; 43():34-39. PubMed ID: 30103073
[TBL] [Abstract][Full Text] [Related]
15. Advancing diabetes treatment: the role of mesenchymal stem cells in islet transplantation.
Mou L; Wang TB; Wang X; Pu Z
Front Immunol; 2024; 15():1389134. PubMed ID: 38605972
[TBL] [Abstract][Full Text] [Related]
16. Co-transplantation of autologous MSCs delays islet allograft rejection and generates a local immunoprivileged site.
Ben Nasr M; Vergani A; Avruch J; Liu L; Kefaloyianni E; D'Addio F; Tezza S; Corradi D; Bassi R; Valderrama-Vasquez A; Usuelli V; Kim J; Azzi J; El Essawy B; Markmann J; Abdi R; Fiorina P
Acta Diabetol; 2015 Oct; 52(5):917-27. PubMed ID: 25808641
[TBL] [Abstract][Full Text] [Related]
17. Strategy for Clinical Setting of Co-transplantation of Mesenchymal Stem Cells and Pancreatic Islets.
Mei L; Yuwei Y; Weiping L; Zhiran X; Bingzheng F; Jibing C; Hongjun G
Cell Transplant; 2024; 33():9636897241259433. PubMed ID: 38877672
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells enhance allogeneic islet engraftment in nonhuman primates.
Berman DM; Willman MA; Han D; Kleiner G; Kenyon NM; Cabrera O; Karl JA; Wiseman RW; O'Connor DH; Bartholomew AM; Kenyon NS
Diabetes; 2010 Oct; 59(10):2558-68. PubMed ID: 20622174
[TBL] [Abstract][Full Text] [Related]
19. The Immunomodulatory Effects of Mesenchymal Stem Cells on Regulatory B Cells.
Liu J; Liu Q; Chen X
Front Immunol; 2020; 11():1843. PubMed ID: 32922398
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stromal cells as a means of controlling pathological T-cell responses in allogeneic islet transplantation.
Reading JL; Sabbah S; Busch S; Tree TI
Curr Opin Organ Transplant; 2013 Feb; 18(1):59-64. PubMed ID: 23222174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
